Author

G. Angarita

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Preliminary evidence of neuroimmune system disruption in opioid use disorder: Findings from a pilot PET TSPO imaging study

Background Preclinical and postmortem human studies demonstrate significant opioid-related alterations in the neuroimmune system. However, studies investigating the neuroimmune system in living people with opioid use disorder (OUD) are lacking, thereby motivating this pilot study. Methods Individuals with OUD (n = 6; D...

E. Woodcock, D. Matuskey, Yi-Yun Huang et al. · Brain, Behavior, & Immunity... · 0 citations

Review Aug 2026

Pharmacotherapies for Co-Occurring Stimulant Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Network Meta-Analysis.

Objective: To evaluate the benefit of pharmacotherapies for adults with co-occurring stimulant use disorder (StUD) and attention-deficit/hyperactivity disorder (ADHD) using network meta-analysis. Data Sources: Searches were conducted of PubMed, Embase, Scopus, Web of Science, and ClinicalTrials.gov from inception to Fe...

H. N. P. Oliva, Alejandra Pulido-Saavedra, Alisson M. Paredes Naveda et al. · Journal of Clinical Psychiat... · 0 citations

Sep 2026

Exploratory imaging in SWEDD: Insights from dopaminergic PET, synaptic density PET, and volumetric MRI.

OBJECTIVE Scans Without Evidence of Dopaminergic Deficit (SWEDD) refers to individuals with Parkinsonian symptoms but no presynaptic dopaminergic deficit on dopamine transporter (DAT) imaging. Given its likely heterogeneity, we used a multimodal imaging approach to compare SWEDD with Parkinson's disease (PD) and health...

Faranak Ebrahimian Sadabad, Tommaso Volpi, Sule Tinaz et al. · Parkinsonism & Related Disor... · 0 citations